Type 2 diabetes | Control | p | |
---|---|---|---|
n | 10 | 10 | |
Male/Female, n (%) | 7/3 (70/30) | 7/3 (70/30) | |
Diabetes duration, years | 3.1 ± 1.8 | - | |
Age, years | 53.4 ± 8.1 | 52.8 ± 10.1 | 0.89 |
Body mass index, kg/m2 | 28.3 ± 3.8 | 28.5 ± 4.2 | 0.91 |
Waist circumference, cm | 107.1 ± 27.5 | 104.4 ± 13.8 | 0.78 |
HbA1c, % (mmol/mol) | 6.4 ± 1.0 (46.0 ± 7.0) | 5.5 ± 0.2 (36.0 ± 1.5) | 0.01 |
HOMA-ir | 2.2 ± 0.7 | 1.7 ± 0.7 | 0.10 |
VO2peak, ml/kg/min | 38.8 ± 7.8 | 36.2 ± 8.8 | 0.51 |
VO2peak, L/min | 3.39 ± 0.84 | 3.36 ± 0.92 | 0.93 |
Medical agents, n (%) | |||
Anti-diabetic | 6 (60) | 0 (0) | |
Statins | 1 (10) | 1 (10) | |
Anti-hypertension | 6 (60) | 1 (10) |